Improved and new treatment

Creating New Treatments for Metastatic Breast Cancer

Advanced estrogen receptor positive (ER+) breast cancer is responsible for over half of breast cance ...
Read more...

Improving Treatment Options for Rare Breast Cancers

Most breast cancers are carcinomas, which are tumours that start in the surface cells that line the ...
Read more...

Repurposing an Existing Therapy for Triple-Negative Breast Cancer

Triple negative breast cancers (TNBCs) are present in up to 20% of breast cancer patients. Unfortun ...
Read more...

Fast-Tracking Pro-Survival Proteins from the Lab to the Clinic

Certain blood cancers are sustained by high levels of a ‘survival’ protein called BCL-2, which m ...
Read more...

Anti-Cancer Drugs for Advanced and Resistant Breast Cancer

Breast cancer tumours can become resistant to treatment through a number of mechanisms, including ch ...
Read more...

Using a State of the Art Tumour Bank to Investigate Drug Resistant Breast Cancer

Metastasis is an incurable spread of cancer and is the main cause of cancer death. It is evident tha ...
Read more...

A New Way to Attack the Most Aggressive Breast Cancer

Despite improvements in outcomes over the past decade, women with aggressive breast cancer subtypes ...
Read more...

Developing New Immunotherapies for Triple-Negative Breast Cancer

A diagnosis of triple-negative breast cancer (TNBC) means that the tumour lacks the three most commo ...
Read more...

Strengthening the Immune System to Fight Breast Cancer Tumours

In the past decade, one of the most exciting advances in the treatment of cancer has been the develo ...
Read more...

New Therapies to Outsmart Treatment Resistance in Aggressive Breast Cancer

Drug therapy is an important part of primary treatment for breast cancer and is the treatment of cho ...
Read more...